Cargando…

Pan-cancer analysis of the PDE4DIP gene with potential prognostic and immunotherapeutic values in multiple cancers including acute myeloid leukemia

Phosphodiesterase 4D interacting protein (PDE4DIP) interacts with cAMP-specific phosphodiesterase 4D and its abnormal expression promotes the development of hematological malignancies, breast cancer, and pineal cell carcinoma. However, there is currently no systematic pan-cancer analysis of the asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Qi, Cheng, Yujing, Chen, Wanlu, Wang, Ying, Dai, Run, Yang, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	De Gruyter 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10473463/ https://www.ncbi.nlm.nih.gov/pubmed/37663233 http://dx.doi.org/10.1515/med-2023-0782

Ejemplares similares

Pan-Cancer Analysis of the Prognostic and Immunotherapeutic Value of MITD1
por: Dong, Shiqiang, et al.
Publicado: (2022)

Prognostic and Immunotherapeutic Roles of KRAS in Pan-Cancer
por: Yang, Kaixin, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of ALKBH7
por: Chen, Kaijie, et al.
Publicado: (2022)

Potential prognostic and immunotherapeutic value of calponin 1: A pan-cancer analysis
por: Zhou, Hengli, et al.
Publicado: (2023)

Pan-cancer analysis shows that IBSP is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including osteosarcoma
por: Pan, Boyu, et al.
Publicado: (2023)

Molecule of the month, PDE4DIP
por: Shapshak, Paul
Publicado: (2012)

Pan-cancer analyses reveal the immunotherapeutic value of klotho
por: Liang, Jinghao, et al.
Publicado: (2022)

Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
por: Wei, Cheng, et al.
Publicado: (2022)

Corrigendum: Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas
por: Wei, Cheng, et al.
Publicado: (2022)

Pan-Cancer analysis shows that ACO2 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including hepatocellular carcinoma
por: Wang, Zhen, et al.
Publicado: (2022)

Pan-cancer analysis supports MAPK12 as a potential prognostic and immunotherapeutic target in multiple tumor types, including in THCA
por: Wang, Jinju, et al.
Publicado: (2022)

A Pan-Cancer Analysis Reveals the Prognostic and Immunotherapeutic Value of Stanniocalcin-2 (STC2)
por: Jiang, Zhong-Hui, et al.
Publicado: (2022)

Pan-cancer analysis reveals the prognostic and immunotherapeutic value of cytoskeleton-associated protein 2-like
por: Yi, Bocun, et al.
Publicado: (2023)

Pan-cancer analysis identifies YTHDF2 as an immunotherapeutic and prognostic biomarker
por: Liu, Weiwei, et al.
Publicado: (2022)

The Prognostic Significance of PDE7B in Cytogenetically Normal Acute Myeloid Leukemia
por: Cao, Ling, et al.
Publicado: (2019)

Integrative study reveals the prognostic and immunotherapeutic value of CD274 and PDCD1LG2 in pan-cancer
por: Zhou, Xuan, et al.
Publicado: (2022)

CCNE1 is a predictive and immunotherapeutic indicator in various cancers including UCEC: a pan-cancer analysis
por: Zheng, Xingyu, et al.
Publicado: (2023)

Recurrent homozygous deletion of DROSHA and microduplication of PDE4DIP in pineoblastoma
por: Snuderl, Matija, et al.
Publicado: (2018)

Pan-cancer analysis of oncogenic TNFAIP2 identifying its prognostic value and immunological function in acute myeloid leukemia
por: Lin, Mei-si, et al.
Publicado: (2022)

PDE4DIP contributes to colorectal cancer growth and chemoresistance through modulation of the NF1/RAS signaling axis
por: Pan, Rulu, et al.
Publicado: (2023)

OLR1 Is a Pan-Cancer Prognostic and Immunotherapeutic Predictor Associated with EMT and Cuproptosis in HNSCC
por: Wu, Lei, et al.
Publicado: (2023)

A Comprehensive Pan-Cancer Analysis of 33 Human Cancers Reveals the Immunotherapeutic Value of Aryl Hydrocarbon Receptor
por: Mo, Zhuomao, et al.
Publicado: (2021)

Multiomics characteristics and immunotherapeutic potential of EZH2 in pan-cancer
por: Luo, Lianghua, et al.
Publicado: (2023)

PSMC2 is a Novel Prognostic Biomarker and Predicts Immunotherapeutic Responses: From Pancreatic Cancer to Pan-Cancer
por: Huang, Wei, et al.
Publicado: (2023)

The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma
por: Li, Wenli, et al.
Publicado: (2022)

The value of WNT5A as prognostic and immunological biomarker in pan-cancer
por: Feng, Yingtong, et al.
Publicado: (2022)

A potential immunotherapeutic and prognostic biomarker for multiple tumors including glioma: SHOX2
por: Wu, Xiaocong, et al.
Publicado: (2023)

Leukemia Associated Antigens: Their Dual Role as Biomarkers and Immunotherapeutic Targets for Acute Myeloid Leukemia
por: Guinn, Barbara-ann, et al.
Publicado: (2007)

Pan-Cancer Analysis and Validation of Opioid-Related Receptors Reveals the Immunotherapeutic Value of Toll-Like Receptor 4
por: Wu, Shaoping, et al.
Publicado: (2023)

SLC31A1 Identifying a Novel Biomarker with Potential Prognostic and Immunotherapeutic Potential in Pan-Cancer
por: Zhang, Pei, et al.
Publicado: (2023)

Cathepsin G is broadly expressed in acute myeloid leukemia and is an effective immunotherapeutic target
por: Alatrash, Gheath, et al.
Publicado: (2016)

Immunological role and prognostic value of the SKA family in pan-cancer analysis
por: Li, Zhengtian, et al.
Publicado: (2023)

Integrated pancancer analysis reveals the oncogene characteristics and prognostic value of DIP2B in breast cancer
por: Song, Chengyang, et al.
Publicado: (2023)

Screening the Cancer Genome Atlas Database for Genes of Prognostic Value in Acute Myeloid Leukemia
por: Ni, Jie, et al.
Publicado: (2020)

Comprehensive Pan-Cancer Analyses of Pyroptosis-Related Genes to Predict Survival and Immunotherapeutic Outcome
por: Wang, Qilin, et al.
Publicado: (2022)

Transcriptome sequencing and single-cell sequencing analysis identify GARS1 as a potential prognostic and immunotherapeutic biomarker for multiple cancers, including bladder cancer
por: Nie, Jianqiang, et al.
Publicado: (2023)

Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia
por: Cheng, Zhiheng, et al.
Publicado: (2021)

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
por: Depreter, Barbara, et al.
Publicado: (2020)

The diagnostic or prognostic values of FADD in cancers based on pan‑cancer analysis
por: Wang, Chenyu, et al.
Publicado: (2023)

Insights Into the Prognostic Value and Immunological Role of NAAA in Pan-Cancer
por: Huang, Da, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jnlu509celk5gs7svovt9j8qli